The Relationship Between Grey Matter Volume and Clinical and Functional Outcomes in People at Clinical High Risk for Psychosis

Stefania Tognin*, Anja Richter, Matthew J. Kempton, Gemma Modinos, Mathilde Antoniades, Matilda Azis, Paul Allen, Matthijs G. Bossong, Jesus Perez, Christos Pantelis, Barnaby Nelson, Paul Amminger, Anita Riecher-Rössler, Neus Barrantes-Vidal, Marie Odile Krebs, Birte Glenthøj, Stephan Ruhrmann, Gabriele Sachs, Bart P. Rutten, Lieuwe De HaanMark Van Der Gaag, Philip Mcguire, Lucia R. Valmaggia, Maria Calem, Mathilde Antoniades, Sara Pisani, Gemma Modinos, Lieuwe De Haan, Mark Van Der Gaag, Eva Velthorst, Tamar C. Kraan, Daniella S. Van Dam, Nadine Burger, Barnaby Nelson, Patrick Mcgorry, G. Paul Amminger, Athena Politis, Joanne Goodall, Anita Riecher-Rössler, Stefan Borgwardt, Erich Studerus, Rodrigo Bressan, Ary Gadelha, Elisa Brietzke, Graccielle Asevedo, Elson Asevedo, Andre Zugman, Neus Barrantes-Vidal, Tecelli Domínguez-Martínez, Anna Racciopi, Thomas R. Kwapil, Manel Monsonet, Lídia Hinojosa, Mathilde Kazes, Claire Daban, Julie Bourgin, Olivier Gay, Celia Mam-Lam-Fook, Marie Odile Krebs, Dorte Nordholm, Lasse Randers, Kristine Krakauer, Louise Glenthøj, Birte Glenthøj, Merete Nordentoft, Stephan Ruhrmann, Dominika Gebhard, Julia Arnhold, Joachim Klosterkötter, Gabriele Sachs, Iris Lasser, Bernadette Winklbaur, Harald Aschauer, Philippe A. Delespaul, Bart P. Rutten, Jim Van Os, Philip Mcguire

*Corresponding author for this work
7   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'The Relationship Between Grey Matter Volume and Clinical and Functional Outcomes in People at Clinical High Risk for Psychosis'. Together they form a unique fingerprint.
Sort by

Neuroscience